Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Fabio Angeli and Gianpaolo Reboldi.
Connection Strength

10.003
  1. RAAS Inhibitors and Risk of Covid-19. N Engl J Med. 2020 Nov 12; 383(20):1990-1991.
    View in: PubMed
    Score: 0.910
  2. Tight Blood Pressure Control Saves Lives in Hypertensive Patients With Chronic Kidney Disease. Hypertension. 2019 06; 73(6):1172-1173.
    View in: PubMed
    Score: 0.826
  3. Amlodipine and celecoxib for treatment of hypertension and osteoarthritis pain. Expert Rev Clin Pharmacol. 2018 Nov; 11(11):1073-1084.
    View in: PubMed
    Score: 0.793
  4. Role and prognostic value of individual ambulatory blood pressure components in chronic kidney disease. J Hum Hypertens. 2018 09; 32(8-9):625-632.
    View in: PubMed
    Score: 0.772
  5. PK/PD evaluation of fimasartan for the treatment of hypertension Current evidences and future perspectives. Expert Opin Drug Metab Toxicol. 2018 May; 14(5):533-541.
    View in: PubMed
    Score: 0.767
  6. Left Ventricular Hypertrophy and Coronary Artery Calcifications: A Dangerous Duet? Am J Hypertens. 2018 02 09; 31(3):287-289.
    View in: PubMed
    Score: 0.754
  7. Perioperative beta blockade: the debate continues. Lancet. 2009 Feb 21; 373(9664):627; author reply 628.
    View in: PubMed
    Score: 0.405
  8. SARS-CoV-2 infection and ACE2 inhibition. J Hypertens. 2021 08 01; 39(8):1555-1558.
    View in: PubMed
    Score: 0.240
  9. Ageing, ACE2 deficiency and bad outcome in COVID-19. Clin Chem Lab Med. 2021 06 14; 59(10):1607-1609.
    View in: PubMed
    Score: 0.238
  10. SARS-CoV-2 vaccines: Lights and shadows. Eur J Intern Med. 2021 06; 88:1-8.
    View in: PubMed
    Score: 0.236
  11. Electrocardiographic features of patients with COVID-19 pneumonia. Eur J Intern Med. 2020 08; 78:101-106.
    View in: PubMed
    Score: 0.222
  12. Angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers and coronavirus. J Hypertens. 2020 06; 38(6):1190-1191.
    View in: PubMed
    Score: 0.221
  13. [ACE-inhibitors, angiotensin receptor blockers and severe acute respiratory syndrome caused by coronavirus]. G Ital Cardiol (Rome). 2020 May; 21(5):321-327.
    View in: PubMed
    Score: 0.220
  14. Response by Verdecchia et al to Letter Regarding Article "Sudden Cardiac Death in Hypertensive Patients". Hypertension. 2019 Jul 01; HYPERTENSIONAHA11913441.
    View in: PubMed
    Score: 0.208
  15. Sudden Cardiac Death in Hypertensive Patients. Hypertension. 2019 05; 73(5):1071-1078.
    View in: PubMed
    Score: 0.205
  16. Managing hypertension in 2018: which guideline to follow? Heart Asia. 2019; 11(1):e011127.
    View in: PubMed
    Score: 0.203
  17. European and US guidelines for arterial hypertension: similarities and differences. Eur J Intern Med. 2019 05; 63:3-8.
    View in: PubMed
    Score: 0.202
  18. Keep Blood Pressure Low, but Not Too Much…. Circ Res. 2018 11 09; 123(11):1205-1207.
    View in: PubMed
    Score: 0.199
  19. [What are the main novelties in the recent US and European guidelines for the management of hypertension?] G Ital Cardiol (Rome). 2018 Nov; 19(11):611-619.
    View in: PubMed
    Score: 0.198
  20. Gathering evidence on the prognostic role of central blood pressure in hypertension. Hypertens Res. 2018 11; 41(11):865-868.
    View in: PubMed
    Score: 0.197
  21. What to Do When Blood Pressure Is Between 130/80 and 139/89 mm Hg? J Am Coll Cardiol. 2018 09 11; 72(11):1198-1200.
    View in: PubMed
    Score: 0.196
  22. The 2018 ESC/ESH hypertension guidelines: Should nephrologists always stop at the lower boundary? J Nephrol. 2018 Oct; 31(5):621-626.
    View in: PubMed
    Score: 0.196
  23. Heart failure, pulse pressure and heart rate: Refining risk stratification. Int J Cardiol. 2018 11 15; 271:206-208.
    View in: PubMed
    Score: 0.194
  24. Hypertension and Atrial Fibrillation: Doubts and Certainties From Basic and Clinical Studies. Circ Res. 2018 01 19; 122(2):352-368.
    View in: PubMed
    Score: 0.188
  25. The Tale of an Innocent: Intensive Treatment and the J-Curve in the SPRINT Trial (Systolic Blood Pressure Intervention Trial). Circulation. 2017 12 05; 136(23):2230-2232.
    View in: PubMed
    Score: 0.186
  26. Intensive Blood Pressure Lowering and Regression of Left Ventricular Hypertrophy. Circulation. 2017 08 01; 136(5):451-453.
    View in: PubMed
    Score: 0.182
  27. Impact of Chamber Dilatation on the Prognostic Value of Left Ventricular Geometry in Hypertension. J Am Heart Assoc. 2017 May 24; 6(6).
    View in: PubMed
    Score: 0.179
  28. How Low Should We Go With Blood Pressure? Circ Res. 2017 01 06; 120(1):27-29.
    View in: PubMed
    Score: 0.175
  29. Does Malaria Cause Hypertension? Circ Res. 2016 06 24; 119(1):7-9.
    View in: PubMed
    Score: 0.168
  30. [Blood pressure: the lower the better? Maybe yes]. G Ital Cardiol (Rome). 2016 May; 17(5):335-8.
    View in: PubMed
    Score: 0.167
  31. [Arterial hypertension: an update]. G Ital Cardiol (Rome). 2010 May; 11(5 Suppl 3):74S-77S.
    View in: PubMed
    Score: 0.110
  32. Dabigatran vs. warfarin in relation to the presence of left ventricular hypertrophy in patients with atrial fibrillation- the Randomized Evaluation of Long-term anticoagulation therapY (RE-LY) study. Europace. 2018 02 01; 20(2):253-262.
    View in: PubMed
    Score: 0.047
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.